Literature DB >> 446038

Rehabilitation of alexia: a case study.

S B Moyer.   

Abstract

This case study described the success of a technique labeled Multiple Oral Rereading (MOR) in the remediation of a case of acquired alexia in an adult male. Unusually slow visual-verbal processing characteristic of this patient is sometimes noted in dyslexic children. The possibility that MOR might prove effective for other selected cases of acquired alexia and "developmental" dyslexia is considered.

Entities:  

Mesh:

Year:  1979        PMID: 446038     DOI: 10.1016/s0010-9452(79)80015-5

Source DB:  PubMed          Journal:  Cortex        ISSN: 0010-9452            Impact factor:   4.027


  5 in total

1.  Multiple Oral Re-reading treatment for alexia: The parts may be greater than the whole.

Authors:  Elizabeth H Lacey; S N Lott; S F Snider; A Sperling; R B Friedman
Journal:  Neuropsychol Rehabil       Date:  2010-07-06       Impact factor: 2.868

2.  Treatment for Alexia With Agraphia Following Left Ventral Occipito-Temporal Damage: Strengthening Orthographic Representations Common to Reading and Spelling.

Authors:  Esther S Kim; Kindle Rising; Steven Z Rapcsak; Pélagie M Beeson
Journal:  J Speech Lang Hear Res       Date:  2015-10       Impact factor: 2.297

3.  Reading therapy strengthens top-down connectivity in patients with pure alexia.

Authors:  Zoe V J Woodhead; William Penny; Gareth R Barnes; Hilary Crewes; Richard J S Wise; Cathy J Price; Alexander P Leff
Journal:  Brain       Date:  2013-08       Impact factor: 13.501

4.  Randomized trial of iReadMore word reading training and brain stimulation in central alexia.

Authors:  Zoe V J Woodhead; Sheila J Kerry; Oscar M Aguilar; Yean-Hoon Ong; John S Hogan; Katerina Pappa; Alex P Leff; Jennifer T Crinion
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

5.  Modified script training for nonfluent/agrammatic primary progressive aphasia with significant hearing loss: A single-case experimental design.

Authors:  Kristin M Schaffer; Lisa Wauters; Karinne Berstis; Stephanie M Grasso; Maya L Henry
Journal:  Neuropsychol Rehabil       Date:  2020-10-07       Impact factor: 2.868

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.